What is the intrinsic value of PVCT?

As of 2025-05-16, the Intrinsic Value of Provectus Biopharmaceuticals Inc (PVCT) is (0.32) USD. This PVCT valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.08 USD, the upside of Provectus Biopharmaceuticals Inc is -484.40%.

The range of the Intrinsic Value is (1.30) - (0.19) USD

Is PVCT undervalued or overvalued?

Based on its market price of 0.08 USD and our intrinsic valuation, Provectus Biopharmaceuticals Inc (PVCT) is overvalued by 484.40%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

	Range	Selected	Upside
a
DCF (Growth 5y)	(1.30) - (0.19)	(0.32)	-484.4%
DCF (Growth 10y)	(0.19) - (1.19)	(0.31)	-470.9%
DCF (EBITDA 5y)	(0.10) - (0.11)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(0.12) - (0.14)	(1,234.50)	-123450.0%
Fair Value	-0.06 - -0.06	-0.06	-167.43%
P/E	(0.03) - (0.06)	(0.05)	-154.3%
EV/EBITDA	(0.07) - (0.07)	(0.07)	-181.4%
EPV	(0.08) - (0.10)	(0.09)	-208.5%
DDM - Stable	(0.17) - (1.43)	(0.80)	-1059.7%
DDM - Multi	(0.14) - (0.92)	(0.25)	-394.3%